MENLO PARK, Calif. (AP) _ Adverum Biotechnologies Inc. (ADVM) on Tuesday reported a loss of $16.1 million in its first quarter.
The Menlo Park, California-based company said it had a loss of 38 cents per share.
The gene therapy company posted revenue of $462,000 in the period.
In the final minutes of trading on Tuesday, the company's shares hit $2.80. A year ago, they were trading at $4.03.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ADVM at https://www.zacks.com/ap/ADVM
Keywords: Adverum Biotechnologies, Earnings Report